Given its exosome-related function, MYOF may act as a candidate protein for EV-modulated tumor growth and spread in breast cancer and small molecule compounds targeting MYOF (e.g., WJ460) seem likely to play an important role in EV-dependent tumor progression. The gene discussed is MYOF; the disease is breast carcinoma.